安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Tempus | AI-enabled precision medicine
Tempus has built the world’s largest library of clinical molecular data and an operating system to make that data accessible and useful, starting with cancer
- Tempus AI - Wikipedia
Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics, [5] for oncology, cardiology, radiology, and depression The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM " [6][7]
- How Investors Are Reacting To Tempus AI (TEM) Earnings Surge and New . . .
Tempus AI recently reported third quarter 2025 earnings, highlighted by revenue of US$334 21 million, up from US$180 93 million a year ago, and an improved net loss, while also announcing a new
- Tempus - compcancercare. com
TEMPUS® is a technology company that has built the world's largest library of clinical and molecular data and an operating system to make that information accessible and useful for patients, physicians and researchers
- Tempus - 2025 Company Profile Team - Tracxn
Tempus is a public company based in Chicago (United States), founded in 2015 by Eric Lefkofsky It operates as an AI-based precision medicine solutions for oncology Tempus has raised $1 05B in funding from investors like New Enterprise Associates, T Rowe Price and Revolution
- What Does Tempus AI Actually Do? Unveiling the AI Revolution in . . .
In 2015, with a vision to revolutionize how doctors use data in clinical settings, Lefkofsky established Tempus The initial aim was to create a system where doctors could access a comprehensive, real-time view of a patient's medical history, including genomic, clinical, and imaging data
- Live: Will Tempus AI Move Higher After Earnings?
Live Updates Get The Best Tempus AI Live Earnings Coverage Like This Every Quarter Get earnings reminders, our top analysis on Tempus AI, market updates, and brand-new stock recommendations
- Tempus AI: Great Buying Opportunity On Recent Weakness
Tempus AI stands out as a leader in healthcare AI, showing strong execution and robust Q3 results despite recent stock volatility Learn more about TEM stock here
|
|
|